PRESS RELEASE published on 10/22/2024 at 22:45, 1 year 3 months ago DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe DBV Technologies announces positive regulatory updates for Viaskin Peanut Patch in the United States and Europe, aiming for Accelerated Approval for toddlers 1-3 years old Accelerated Approval Regulatory Updates DBV Technologies Viaskin Peanut Patch Toddlers
BRIEF published on 10/18/2024 at 22:35, 1 year 3 months ago DBV Technologies to Engage in ACAAI 2024 Congress DBV Technologies Allergy Treatment Peanut Allergy Viaskin Peanut Patch ACAAI 2024
PRESS RELEASE published on 10/18/2024 at 22:30, 1 year 3 months ago DBV Technologies to Participate in Upcoming ACAAI 2024 Congress DBV Technologies to participate in ACAAI 2024 Congress, presenting on optimal peanut allergy treatment and sponsoring FIT Bowl. Viaskin Peanut patch for food allergies highlighted DBV Technologies Food Allergies Viaskin Peanut Patch ACAAI 2024 Congress Peanut Allergy Treatment
BRIEF published on 10/14/2024 at 22:35, 1 year 3 months ago DBV Technologies Share Capital Status as of September 30, 2024 Share Capital Voting Rights DBV Technologies Euronext Exchanges Listed Shares
BRIEF published on 09/23/2024 at 22:35, 1 year 4 months ago DBV Technologies Completes Screening of Subjects for Phase 3 VITESSE Clinical Trial Clinical Trial Phase 3 DBV Technologies Viaskin Peanut Peanut Allergy
PRESS RELEASE published on 09/23/2024 at 22:30, 1 year 4 months ago DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial DBV Technologies completes screening for VITESSE Phase 3 Clinical Trial evaluating Viaskin Peanut Patch in peanut allergic children ages 4-7. Topline results expected Q4 2025 Clinical Trial DBV Technologies Food Allergies VITESSE Phase 3 Viaskin Peanut Patch
BRIEF published on 09/04/2024 at 22:35, 1 year 4 months ago DBV Technologies to Participate in 26th Annual HC Wainwright Global Investment Conference DBV Technologies Viaskin Food Allergies HC Wainwright Lecture Epicutaneous Immunotherapy
PRESS RELEASE published on 09/04/2024 at 22:30, 1 year 4 months ago DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference DBV Technologies to participate in H.C. Wainwright 26th Annual Global Investment Conference with CEO Daniel Tassé in New York City. Focus on food allergy treatment and immunotherapy Immunotherapy DBV Technologies Food Allergies H.C. Wainwright Conference VIASKIN Patch
BRIEF published on 08/02/2024 at 22:35, 1 year 5 months ago DBV Technologies: Information as of July 31, 2024 on the number of shares and voting rights Share Capital Voting Rights AMF DBV Technologies NYSE Euronext Paris
PRESS RELEASE published on 08/02/2024 at 22:30, 1 year 5 months ago Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024 Details of total voting rights and shares of the Company as of July 31, 2024 under AMF regulations Voting Rights Shares AMF Regulations Company July 31 2024
Published on 01/30/2026 at 02:15, 2 hours 31 minutes ago Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 4 hours 46 minutes ago LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/29/2026 at 23:00, 5 hours 46 minutes ago PPX Mining Announces Filing of 2025 Audited Financial Statements and MD&A
Published on 01/29/2026 at 18:45, 10 hours 1 minute ago Silver Spruce Appoints Vice-President of Exploration
Published on 01/29/2026 at 18:00, 10 hours 46 minutes ago PPX Mining Announces Grant of Restricted Share Units and Deferred Share Units
Published on 01/30/2026 at 04:30, 16 minutes ago A First Look at AI in the Real World: AWE 2026 Opens This March in Shanghai
Published on 01/30/2026 at 03:35, 1 hour 11 minutes ago Bybit Unveils 2026 Vision as "The New Financial Platform," Expanding Beyond Exchange Into Global Financial Infrastructure
Published on 01/30/2026 at 00:07, 4 hours 38 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appointment of independent non-executive director
Published on 01/29/2026 at 21:02, 7 hours 43 minutes ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/29/2026 at 21:01, 7 hours 45 minutes ago Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 01/29/2026 at 18:00, 10 hours 46 minutes ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 11 hours 1 minute ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 11 hours 1 minute ago Cegedim generated LFL revenue growth of 1.1% in 2025
Published on 01/29/2026 at 10:07, 18 hours 38 minutes ago Deezer confirms demonetization of up to 85% of AI-music streams due to fraud and moves to sell AI-detection tech
